National Bank of Canada’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-800
Closed -$9.85M 2782
2023
Q4
$9.85M Buy
+800
New +$81.7K 0.02% 581

Other funds holding DXCM

National Bank of Canada's DXCM Position: Q2 2026 in Review

National Bank of Canada reduced its DexCom (DXCM) stake by 43% in Q2 2026, selling an estimated $53.7M and leaving 1,065,517 shares worth $71.8M. The position accounts for 0.05% of the portfolio, ranked #278.

National Bank of Canada first reported a position in DXCM in Q4 2021 and has held it in 19 quarters since. The position peaked at $117M in Q1 2026. 564 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • National Bank of Canada held 1,065,517 shares of DexCom worth $71.8M as of Q2 2026.
  • National Bank of Canada sold 805,454 DexCom shares in Q2 2026, an estimated $53.7M.
  • DexCom made up 0.05% of National Bank of Canada's portfolio in Q2 2026, its #278 holding.
  • National Bank of Canada first reported a position in DexCom in Q4 2021 and has held it in 19 quarters since.
  • National Bank of Canada's DexCom position peaked at $117M in Q1 2026.
  • 564 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.